F8Z-29032-03713
4 vaccinations
5 coded responses
52 check-ins
5 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 981 / WA
- Registered
- 2021-05-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-12
Registered in v-safe
-
2021-05-12
Dose 1 — Pfizer-BioNTech
-
2021-05-12
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: Good · Site: Pain · Muscle or body achesFree text: Ache clarification: Very minor soreness around injection site like like most intramuscular injections.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: Pain · Muscle or body achesFree text: Again, minor soreness around the injection site, started more sore than yesterday but lessening through the day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-17
- 2021-05-18
- 2021-05-19
- 2021-05-26
-
2021-06-02
Dose 2 — Pfizer-BioNTech
- 2021-06-02
- 2021-06-03
- 2021-06-04
- 2021-06-05
- 2021-06-06
- 2021-06-07
- 2021-06-08
- 2021-06-09
- 2021-06-16
- 2021-06-23
- 2021-06-30
- 2021-07-07
- 2021-07-14
- 2021-09-01
- 2021-12-01
-
2022-01-11
Dose 3 — Moderna
- 2022-01-11
- 2022-01-12
- 2022-01-13
-
2022-01-14
Survey response — days 1–6 daily, dose 3MedDRA: Injection site discomfort, Injection site pain — Feeling: Good · Site: Pain · Muscle or body achesFree text: Injection site soreness has diminished substantially, yesterday was the most uncomfortableMedDRA releases: 2024-11 · check-in free text available
-
2022-01-15
Survey response — days 1–6 daily, dose 3MedDRA: Injection site pain — Feeling: Good · Site: Pain · Muscle or body achesFree text: Very slight injection site pain when manipulatedMedDRA releases: 2024-11 · check-in free text available
- 2022-01-16
- 2022-01-17
- 2022-01-20
- 2022-01-25
- 2022-02-01
- 2022-02-08
- 2022-02-15
- 2022-02-22
- 2022-04-12
-
2022-07-12
Survey response — 6 months, dose 3MedDRA: Cough, Decreased appetite, Disturbance in attention, Fatigue, Influenza virus test negative, Medical counselling, Night sweats, Productive cough, Pyrexia, SARS-CoV-2 test negative, Suspected COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: fever over 104F for >5 days, extreme night sweats, fatigue, lack of appetite, poor concentration, productive cough turned dry cough after a few days. All covid-19, STREP, flu, and bacterial infection tests came back negative, Dr said: probably covid.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-12
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-07-13
-
2022-07-13
Call successfulParticipant prefers to complete VAERS report online
-
2023-03-25
Dose 4 — Pfizer-BioNTech
- 2023-03-25
- 2023-03-27
- 2023-03-28
- 2023-03-29
- 2023-03-30
- 2023-03-31
- 2023-04-01
- 2023-04-08
- 2023-04-17
- 2023-04-22
- 2023-04-29
- 2023-05-06
- 2023-06-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-12 | Pfizer-BioNTech | |
| 2 | 2021-06-02 | Pfizer-BioNTech | |
| 3 | 2022-01-11 | Moderna | No |
| 4 | 2023-03-25 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 8 — day 0, dose 1
Systemic reaction (other): Ache clarification: Very minor soreness around injection site like like most intramuscular injections.
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Again, minor soreness around the injection site, started more sore than yesterday but lessening through the day.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Injection site soreness has diminished substantially, yesterday was the most uncomfortable
Systemic reaction (other): Very slight injection site pain when manipulated
Release 12 — 6 months, dose 3
Symptoms: fever over 104F for >5 days, extreme night sweats, fatigue, lack of appetite, poor concentration, productive cough turned dry cough after a few days. All covid-19, STREP, flu, and bacterial infection tests came back negative, Dr said: probably covid. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Disturbance in attention | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Influenza virus test negative | · | · | ✓ |
| SD | Medical counselling | · | · | ✓ |
| SD | Night sweats | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Suspected COVID-19 | · | · | ✓ |
| SRO | Injection site discomfort | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release